<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05083442</url>
  </required_header>
  <id_info>
    <org_study_id>21-008379</org_study_id>
    <nct_id>NCT05083442</nct_id>
  </id_info>
  <brief_title>Low-level Laser and Lifestyle Modifications</brief_title>
  <acronym>LLLT</acronym>
  <official_title>A Feasibility Study Addressing the Adjunct Use of Low-Level Laser to Mayo Lifestyle Modification Education and Wellness Coaching for Reducing Central Adiposity and Fat Mass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Erchonia Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to evaulate the effectiveness of Low Level Laser&#xD;
      Therapy in combination with Lifestyle Modifications in helping people reduce the extra weight&#xD;
      and size in the central body region&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will undergo Low Level Laser Therapy or Sham (placebo) treatments while&#xD;
      incorporating lifestyle modifications through of wellness coaching.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized clinical trial where subjects are placed into 2 different study arms. Subjects randomized to 2 groups that either receive Low Level Laser therapy with lifestyle modifications or Sham (placebo) with Lifestyle Modifications.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Randomization will be set up by a statistician through REDCap, the data collection system utilized for the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of fat mass loss</measure>
    <time_frame>6 weeks</time_frame>
    <description>Compare the amount of fat mass loss at the end of treatments</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Overweight and Obesity</condition>
  <condition>Weight Loss</condition>
  <arm_group>
    <arm_group_label>Group 1 - LLLT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject receive Laser treatments and Lifestyle Modifications</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 - SHAM</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Subject receives Sham Laser treatments and Lifestyle Modifications</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low Level Laser Therapy</intervention_name>
    <description>Non-surgical cosmetic treatment which can be used by individuals intending to reduce size of the mid-section</description>
    <arm_group_label>Group 1 - LLLT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham (placebo)</intervention_name>
    <description>Use of sham (placebo) option</description>
    <arm_group_label>Group 2 - SHAM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18 years of age or older&#xD;
&#xD;
          2. have a BMI 25-39.9 kg/m2&#xD;
&#xD;
          3. be able to participate fully in all aspects of the study; and&#xD;
&#xD;
          4. have understood and signed study informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. have used weight loss medications or participated in a weight loss program within the&#xD;
             past 30 days&#xD;
&#xD;
          2. are currently taking medications or supplements known to affect weight, such as&#xD;
             insulin or sulfonylurea, prednisone or garcinia cambrogia&#xD;
&#xD;
          3. have had weight fluctuations of 5 pounds or more in the past month&#xD;
&#xD;
          4. have an implanted device (including pacemaker or lap band) in the targeted area of&#xD;
             LLLT&#xD;
&#xD;
          5. have a known active eating disorder&#xD;
&#xD;
          6. have a known, active, untreated clinically significant psychiatric condition (alcohol&#xD;
             or substance abuse, psychosis, bipolar disorder, or depression)&#xD;
&#xD;
          7. have used an investigational drug within 30 days of study enrollment&#xD;
&#xD;
          8. Reports being currently pregnant, lactating, or are of child-bearing potential or are&#xD;
             likely to become pregnant during the low-level laser therapy treatment phase and are&#xD;
             unwilling to use a reliable form of contraception. Acceptable forms include:&#xD;
&#xD;
               1. Hormonal methods, such as birth control pills, patches, injections, vaginal ring,&#xD;
                  or implants&#xD;
&#xD;
               2. Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam,&#xD;
                  cream, or gel that kills sperm)&#xD;
&#xD;
               3. Intrauterine device (IUD)&#xD;
&#xD;
               4. Total hysterectomy or tubal ligation&#xD;
&#xD;
               5. Abstinence (no sex)&#xD;
&#xD;
          9. have a history of any major cardiovascular events including heart valve disease,&#xD;
             ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary&#xD;
             syndrome, stroke, transient ischemic attack, or peripheral vascular disease&#xD;
&#xD;
         10. have current uncontrolled hypertension (systolic &gt; 160 mm Hg or diastolic &gt; 95 mm Hg)&#xD;
             documented on 2 separate occasions&#xD;
&#xD;
         11. have clinically significant acute or chronic progressive or unstable neurologic,&#xD;
             hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease (such as&#xD;
             uncontrolled diabetes type 2) or active cancer or are within 1 year of cancer&#xD;
             remission&#xD;
&#xD;
         12. surgical intervention for body sculpting/weight loss, such as liposuction,&#xD;
             abdominoplasty, stomach stapling, lap band surgery, etc. within 12 months prior to&#xD;
             enrollment&#xD;
&#xD;
         13. medical, physical, or other contraindications for body sculpting/weight loss&#xD;
&#xD;
         14. any medical condition known to affect weight levels and/or to cause bloating or&#xD;
             swelling&#xD;
&#xD;
         15. a diagnosis of, and/or taking medication for, irritable bowel syndrome&#xD;
&#xD;
         16. active infection, wound or other external trauma to the areas to be treated with the&#xD;
             laser&#xD;
&#xD;
         17. known photosensitivity disorder&#xD;
&#xD;
         18. current active cancer or currently receiving treatment for cancer; or&#xD;
&#xD;
         19. have a known history of any condition or factor judged by the investigator to preclude&#xD;
             participation in the study or which might hinder adherence&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivana T Croghan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Medicine, College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ryan T Hurt, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shawn C Fokken, BS</last_name>
    <phone>507-293-2740</phone>
    <email>GIMResearchStudies@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gillian Currie, MBA</last_name>
    <phone>507-293-2740</phone>
    <email>GIMResearchStudies@mayo.edu</email>
  </overall_contact_backup>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Ivana Croghan</investigator_full_name>
    <investigator_title>Professor of Medicine, College of Medicine</investigator_title>
  </responsible_party>
  <keyword>BMI</keyword>
  <keyword>Fat Mass</keyword>
  <keyword>Weight Loss</keyword>
  <keyword>Body Circumference Reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

